Exact Mass: 630.4495

Caldariellaquinone

C39H66O2S2 (630.4504)

A 1-benzothiophene that is 1-benzothiophene-4,7-dione bearing additional methylthio and 3,7,11,15,19,23-hexamethyltetracosyl substituents at positions 5 and 6 respectively. Isolated from Caldariella acidophila.

4-Methoxycinnamoyloleanolic acid methyl ester

C41H58O5 (630.4284)

4-Methoxycinnamoyloleanolic acid methyl ester is a constituent of Eucalyptus globulus (Tasmanian blue gum). Constituent of Eucalyptus globulus (Tasmanian blue gum).

PA(a-13:0/18:2(9Z,11Z))

C34H63O8P (630.426)

PA(a-13:0/18:2(9Z,11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/18:2(9Z,11Z)), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(i-13:0/18:2(9Z,11Z))

C34H63O8P (630.426)

PA(i-13:0/18:2(9Z,11Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/18:2(9Z,11Z)), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

4-O-Methyl-12-O-tetradecanoylphorbol 13-acetate

C37H58O8 (630.4131)

Dexamethasone palmitate

C38H59FO6 (630.4295)

trans-1,4-Bis[[1-cyclohexyl-3-(4-dimethylamino phenyl)ureido]methyl]cyclohexane

C38H58N6O2 (630.4621)

DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/13:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/13:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C39H66O6 (630.4859)

DG(16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/16:0/0:0)

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C39H66O6 (630.4859)

DG(16:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/16:0)

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C39H66O6 (630.4859)

DG(16:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/16:0/0:0)

C39H66O6 (630.4859)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C39H66O6 (630.4859)

DG(16:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/16:0)

C39H66O6 (630.4859)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C39H66O6 (630.4859)

DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/16:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C39H66O6 (630.4859)

DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/16:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C39H66O6 (630.4859)

DG(16:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/16:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(16:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C39H66O6 (630.4859)

DG(16:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/16:0)

C39H66O6 (630.4859)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/a-13:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/a-13:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-13:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-13:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C39H66O6 (630.4859)

DG(i-16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-16:0/0:0)

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C39H66O6 (630.4859)

DG(i-16:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-16:0)

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C39H66O6 (630.4859)

DG(i-16:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-16:0/0:0)

C39H66O6 (630.4859)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C39H66O6 (630.4859)

DG(i-16:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-16:0)

C39H66O6 (630.4859)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C39H66O6 (630.4859)

DG(i-16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C39H66O6 (630.4859)

DG(i-16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-16:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C39H66O6 (630.4859)

DG(i-16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C39H66O6 (630.4859)

DG(i-16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-16:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C39H66O6 (630.4859)

DG(i-16:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C39H66O6 (630.4859)

DG(i-16:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-16:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C39H66O6 (630.4859)

DG(i-16:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-16:0/0:0)

C39H66O6 (630.4859)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C39H66O6 (630.4859)

DG(i-16:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-16:0)

C39H66O6 (630.4859)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Donhepocin

C35H66O9 (630.4707)

12-O-(2-Methylbutyryl)phorbol-13-dodecanoate

C37H58O8 (630.4131)

Saniculagenin A

C37H58O8 (630.4131)

fomitoside F

C37H58O8 (630.4131)

A triterpene glycoside that consists of lanost-8,24-dien-21-oic acid substituted at by a alpha-acetyloxy group at position 3 and a beta-D-xylopyranosyl moiety at position 21 via a glycosidic linkage. Isolated from the fruit body of Fomitopsis pinicola, it exhibits inhibitory activity against COX-1 and COX-2.

PM-toxin C

C35H66O9 (630.4707)

C38H62O7

C38H62O7 (630.4495)

C37H58O8

C37H58O8 (630.4131)

12-Tigloyl,22-Ac-12-Oleanene-3,26,21,22,24,28-hexol|21-Tigloyl,22-Ac -(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,24,28-hexol

C37H58O8 (630.4131)

(25S,3S)-(+)-12alpha-hydroxy-3alpha-(3-hydroxy-3-methylglutaryloxy)-24-methyllanosta-8,24(31)-dien-26-oic acid

C37H58O8 (630.4131)

Argiopinin IV

C31H54N10O4 (630.4329)

beta-amyrin-3-O-2-O-acetyl-beta-D-glucoside

C38H62O7 (630.4495)

cyclomargenyl-3-O-beta-feruloyl ester

C42H62O4 (630.4648)

3-O-(3-O-acetyl)-alpha-L-arabinopyranosyloleanolic acid

C37H58O8 (630.4131)

3-O-(4-O-acetyl)-alpha-L-arabinopyranosyloleanolic acid

C37H58O8 (630.4131)

8beta-(4-steraoyloxyisoraleroyloxy)9beta-hydroxycostunolide|8beta-<4-steraoyloxyisoraleroyloxy>9beta-hydroxycostunolide

C38H62O7 (630.4495)

C41H58O5

C41H58O5 (630.4284)

Pittobrevigenin

C37H58O8 (630.4131)

21-Tiglooy,16-Ac-12-Oleanene-3,26,21,22,24,28-hexol|21-Tigloyl,16-Ac-(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,24,28-hexol

C37H58O8 (630.4131)

PE-Cer(d14:1/18:1(9Z))

C34H67N2O6P (630.4736)

PE-Cer(d14:2(4E,6E)/18:0)

C34H67N2O6P (630.4736)

PE-Cer(d16:2(4E,6E)/16:0)

C34H67N2O6P (630.4736)

PA(13:0/18:2(9Z,12Z))

C34H63O8P (630.426)

PA(14:0/17:2(9Z,12Z))

C34H63O8P (630.426)

PA(14:1(9Z)/17:1(9Z))

C34H63O8P (630.426)

PA(15:1(9Z)/16:1(9Z))

C34H63O8P (630.426)

PA(16:1(9Z)/15:1(9Z))

C34H63O8P (630.426)

PA(17:1(9Z)/14:1(9Z))

C34H63O8P (630.426)

PA(17:2(9Z,12Z)/14:0)

C34H63O8P (630.426)

PA(18:2(9Z,12Z)/13:0)

C34H63O8P (630.426)

PA(P-16:0/16:1(9Z))

C35H67O7P (630.4624)

PA(P-18:0/14:1(9Z))

C35H67O7P (630.4624)

4-Methoxycinnamoyloleanolic acid methyl ester

C41H58O5 (630.4284)

PA 31:2

C34H63O8P (630.426)

PA O-32:2

C35H67O7P (630.4624)

CerPE 32:2;O2

C34H67N2O6P (630.4736)

3beta,5beta,10beta,14beta-tetrahydroxy-19-norbufa-20,22-dienolide-3-(14-hydroxy-myristate

C37H58O8 (630.4131)

Zinc stearate

C36H70O4Zn (630.4565)

Nutrient supplement

Tetradecanoic acid,(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-7b-hydroxy-3-(hydroxymethyl)-4a-methoxy-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azu

C37H58O8 (630.4131)

(11β,16α)-9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4 -dien-21-yl palmitate

C38H59FO6 (630.4295)

Tri-Isodecyl Trimellitate

C39H66O6 (630.4859)

Magnesium stearate

C36H70O4Zn (630.4565)

It is used in foods as a binder, emulsifier, anticaking agent, lubricant and release agent, nutrient supplement, defoaming agent and processing aid.

Dexamethasone Palmitate

C38H59FO6 (630.4295)

1-Cyclohexyl-1-[[4-[[cyclohexyl-[[4-(dimethylamino)phenyl]carbamoyl]amino]methyl]cyclohexyl]methyl]-3-[4-(dimethylamino)phenyl]urea

C38H58N6O2 (630.4621)

3,4-Dihydroxy-5-all-trans-heptaprenylbenzoic acid

C42H62O4 (630.4648)

DG(16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/16:0/0:0)

C39H66O6 (630.4859)

DG(16:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/16:0)

C39H66O6 (630.4859)

DG(i-16:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-16:0/0:0)

C39H66O6 (630.4859)

DG(i-16:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C39H66O6 (630.4859)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-16:0)

C39H66O6 (630.4859)

DG(16:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C39H66O6 (630.4859)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/16:0/0:0)

C39H66O6 (630.4859)

DG(16:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C39H66O6 (630.4859)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/16:0)

C39H66O6 (630.4859)

DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/16:0/0:0)

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/16:0)

C39H66O6 (630.4859)

DG(16:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/16:0/0:0)

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/16:0)

C39H66O6 (630.4859)

DG(16:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/16:0/0:0)

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C39H66O6 (630.4859)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/16:0)

C39H66O6 (630.4859)

DG(16:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C39H66O6 (630.4859)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/16:0/0:0)

C39H66O6 (630.4859)

DG(16:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C39H66O6 (630.4859)

DG(13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/13:0/0:0)

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/13:0)

C38H62O7 (630.4495)

DG(13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/13:0/0:0)

C38H62O7 (630.4495)

DG(13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/13:0)

C38H62O7 (630.4495)

DG(a-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/a-13:0/0:0)

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/a-13:0)

C38H62O7 (630.4495)

DG(a-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/a-13:0/0:0)

C38H62O7 (630.4495)

DG(a-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/a-13:0)

C38H62O7 (630.4495)

DG(i-13:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/i-13:0/0:0)

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C38H62O7 (630.4495)

DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/i-13:0)

C38H62O7 (630.4495)

DG(i-13:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/i-13:0/0:0)

C38H62O7 (630.4495)

DG(i-13:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C38H62O7 (630.4495)

DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/i-13:0)

C38H62O7 (630.4495)

NAGlySer 18:4/13:1

C36H58N2O7 (630.4244)

NAGlySer 18:5/13:0

C36H58N2O7 (630.4244)

NAGlySer 16:4/15:1

C36H58N2O7 (630.4244)

NAGlySer 20:5/11:0

C36H58N2O7 (630.4244)

Mgdg O-24:1_2:0

C35H66O9 (630.4707)

Mgdg O-19:1_7:0

C35H66O9 (630.4707)

Mgdg O-17:1_9:0

C35H66O9 (630.4707)

Mgdg O-20:1_6:0

C35H66O9 (630.4707)

Mgdg O-18:1_8:0

C35H66O9 (630.4707)

Mgdg O-21:1_5:0

C35H66O9 (630.4707)

Mgdg O-8:0_18:1

C35H66O9 (630.4707)

Mgdg O-9:0_17:1

C35H66O9 (630.4707)

Mgdg O-22:1_4:0

C35H66O9 (630.4707)

Mgdg O-13:0_13:1

C35H66O9 (630.4707)

Mgdg O-16:1_10:0

C35H66O9 (630.4707)

Mgdg O-13:1_13:0

C35H66O9 (630.4707)

Mgdg O-10:0_16:1

C35H66O9 (630.4707)

Mgdg O-14:1_12:0

C35H66O9 (630.4707)

Mgdg O-15:1_11:0

C35H66O9 (630.4707)

Mgdg O-12:0_14:1

C35H66O9 (630.4707)

Mgdg O-11:0_15:1

C35H66O9 (630.4707)

PE-Cer 14:2;2O/18:0

C34H67N2O6P (630.4736)

PE-Cer 15:2;2O/17:0

C34H67N2O6P (630.4736)

PE-Cer 16:0;2O/16:2

C34H67N2O6P (630.4736)

PE-Cer 12:1;2O/20:1

C34H67N2O6P (630.4736)

PE-Cer 13:1;2O/19:1

C34H67N2O6P (630.4736)

PE-Cer 19:2;2O/13:0

C34H67N2O6P (630.4736)

PE-Cer 16:1;2O/16:1

C34H67N2O6P (630.4736)

PE-Cer 19:1;2O/13:1

C34H67N2O6P (630.4736)

PE-Cer 18:1;2O/14:1

C34H67N2O6P (630.4736)

PE-Cer 12:2;2O/20:0

C34H67N2O6P (630.4736)

PE-Cer 12:0;2O/20:2

C34H67N2O6P (630.4736)

PE-Cer 16:2;2O/16:0

C34H67N2O6P (630.4736)

PE-Cer 14:0;2O/18:2

C34H67N2O6P (630.4736)

PE-Cer 18:2;2O/14:0

C34H67N2O6P (630.4736)

PE-Cer 14:1;2O/18:1

C34H67N2O6P (630.4736)

PE-Cer 15:1;2O/17:1

C34H67N2O6P (630.4736)

PE-Cer 13:2;2O/19:0

C34H67N2O6P (630.4736)

PE-Cer 13:0;2O/19:2

C34H67N2O6P (630.4736)

PE-Cer 17:2;2O/15:0

C34H67N2O6P (630.4736)

PE-Cer 17:1;2O/15:1

C34H67N2O6P (630.4736)

PE-Cer 15:0;2O/17:2

C34H67N2O6P (630.4736)

PE-Cer 20:2;2O/12:0

C34H67N2O6P (630.4736)

PE-Cer 15:1;2O/16:2;O

C33H63N2O7P (630.4373)

PE-Cer 15:2;2O/16:1;O

C33H63N2O7P (630.4373)

PE-Cer 17:2;2O/14:1;O

C33H63N2O7P (630.4373)

PE-Cer 13:2;2O/18:1;O

C33H63N2O7P (630.4373)

PE-Cer 18:3;2O/13:0;O

C33H63N2O7P (630.4373)

PE-Cer 12:2;2O/19:1;O

C33H63N2O7P (630.4373)

PE-Cer 17:3;2O/14:0;O

C33H63N2O7P (630.4373)

PE-Cer 15:3;2O/16:0;O

C33H63N2O7P (630.4373)

PE-Cer 13:1;2O/18:2;O

C33H63N2O7P (630.4373)

PE-Cer 18:2;2O/13:1;O

C33H63N2O7P (630.4373)

PE-Cer 19:3;2O/12:0;O

C33H63N2O7P (630.4373)

PE-Cer 16:3;2O/15:0;O

C33H63N2O7P (630.4373)

PE-Cer 16:2;2O/15:1;O

C33H63N2O7P (630.4373)

PE-Cer 14:3;2O/17:0;O

C33H63N2O7P (630.4373)

PE-Cer 19:2;2O/12:1;O

C33H63N2O7P (630.4373)

[(E)-3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(octanoylamino)henicosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-(butanoylamino)-3-hydroxypentacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-(hexanoylamino)-3-hydroxytricosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(nonanoylamino)icosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(pentanoylamino)tetracosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(propanoylamino)hexacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-(heptanoylamino)-3-hydroxydocosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-acetamido-3-hydroxyheptacosa-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(undecanoylamino)octadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-(hexadecanoylamino)-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-(decanoylamino)-3-hydroxynonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxydodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-(heptadecanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

PMeOH 13:1_17:1

C34H63O8P (630.426)

PMeOH 15:1_15:1

C34H63O8P (630.426)

PMeOH 13:0_17:2

C34H63O8P (630.426)

PEtOH 14:1_15:1

C34H63O8P (630.426)

PEtOH 12:0_17:2

C34H63O8P (630.426)

PMeOH 12:0_18:2

C34H63O8P (630.426)

PMeOH 14:1_16:1

C34H63O8P (630.426)

PMeOH 14:0_16:2

C34H63O8P (630.426)

PEtOH 13:0_16:2

C34H63O8P (630.426)

PEtOH 13:1_16:1

C34H63O8P (630.426)

Fahfa 22:6/20:4

C42H62O4 (630.4648)

Fahfa 20:5/22:5

C42H62O4 (630.4648)

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-nonadec-9-enoate

C34H62O10 (630.4343)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-icos-11-enoate

C34H62O10 (630.4343)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-docos-13-enoate

C34H62O10 (630.4343)

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C34H62O10 (630.4343)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C34H62O10 (630.4343)

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-henicos-11-enoate

C34H62O10 (630.4343)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-octadec-9-enoate

C34H62O10 (630.4343)

[1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tetradec-9-enoate

C34H62O10 (630.4343)

[1-dodecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate

C34H62O10 (630.4343)

[1-decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-pentadec-9-enoate

C34H62O10 (630.4343)

[2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-2-(dodecanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(tridecanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(tetradecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(4E,8E)-3-hydroxy-2-(pentadecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate

C34H63O8P (630.426)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C34H63O8P (630.426)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate

C34H63O8P (630.426)

[1-phosphonooxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C34H63O8P (630.426)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C34H63O8P (630.426)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-octadec-9-enoate

C34H63O8P (630.426)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C34H63O8P (630.426)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C34H63O8P (630.426)

[1-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (Z)-hexadec-9-enoate

C34H63O8P (630.426)

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C34H63O8P (630.426)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C34H63O8P (630.426)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C34H63O8P (630.426)

[(E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (11E,14E)-icosa-11,14-dienoate

C34H63O8P (630.426)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (5E,8E)-icosa-5,8-dienoate

C34H63O8P (630.426)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (9E,11E)-octadeca-9,11-dienoate

C34H63O8P (630.426)

[(2S,3R,4E,6E)-3-hydroxy-2-(pentadecanoylamino)tetradeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(2R,3S,4E,8E)-2-(decanoylamino)-3-hydroxynonadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-heptadec-9-enoate

C34H63O8P (630.426)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

C34H63O8P (630.426)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

C34H63O8P (630.426)

[(2S,3R,4E,6E)-3-hydroxy-2-(tetradecanoylamino)pentadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(2S,3R,4E,8E)-2-(dodecanoylamino)-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-9-enoate

C34H63O8P (630.426)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoate

C41H58O5 (630.4284)

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C34H63O8P (630.426)

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C34H63O8P (630.426)

[(2S,3R,4E,8E)-3-hydroxy-2-(tridecanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[1-carboxy-3-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H60NO7+ (630.437)

[(2S)-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C34H62O10 (630.4343)

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-hexadec-7-enoate

C34H63O8P (630.426)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (9E,12E)-octadeca-9,12-dienoate

C34H63O8P (630.426)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C34H63O8P (630.426)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

C34H63O8P (630.426)

[1-carboxy-3-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium

C37H60NO7+ (630.437)

[(2S,3R,4E,8E)-3-hydroxy-2-(tetradecanoylamino)pentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (4E,7E)-hexadeca-4,7-dienoate

C34H63O8P (630.426)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-heptadec-9-enoate

C34H63O8P (630.426)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoate

C41H58O5 (630.4284)

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (E)-hexadec-9-enoate

C34H63O8P (630.426)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (5E,8E)-icosa-5,8-dienoate

C34H63O8P (630.426)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

C34H63O8P (630.426)

[(2R)-2-decanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-pentadec-9-enoate

C34H62O10 (630.4343)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (E)-pentadec-9-enoate

C34H62O10 (630.4343)

[1-carboxy-3-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C37H60NO7+ (630.437)

[(2S)-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] (E)-tetradec-9-enoate

C34H62O10 (630.4343)

[(2S,3R,4E,6E)-3-hydroxy-2-(tridecanoylamino)hexadeca-4,6-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (6E,9E)-octadeca-6,9-dienoate

C34H63O8P (630.426)

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] (E)-hexadec-7-enoate

C34H63O8P (630.426)

[1-carboxy-3-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C37H60NO7+ (630.437)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (2E,4E)-octadeca-2,4-dienoate

C34H63O8P (630.426)

[(2S,3R,4E,8E)-3-hydroxy-2-(pentadecanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H67N2O6P (630.4736)

2-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H61NO8P+ (630.4135)

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C37H60NO7+ (630.437)

2-[[3-heptanoyloxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H61NO8P+ (630.4135)

2-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-hexanoyloxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-butanoyloxy-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[hydroxy-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C33H61NO8P+ (630.4135)

2-[[2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C33H61NO8P+ (630.4135)

2-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[3-decoxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-decanoyloxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

2-[[2-acetyloxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H65NO7P+ (630.4498)

1-tridecanoyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

C34H63O8P (630.426)

BisMePA(30:2)

C35H67O7P (630.4624)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

OAHFA(42:10)

C42H62O4 (630.4648)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 16:3/O-26:7

C42H62O4 (630.4648)

FAHFA 16:4/O-26:6

C42H62O4 (630.4648)

FAHFA 16:5/O-26:5

C42H62O4 (630.4648)

FAHFA 17:3/O-25:7

C42H62O4 (630.4648)

FAHFA 17:4/O-25:6

C42H62O4 (630.4648)

FAHFA 17:5/O-25:5

C42H62O4 (630.4648)

FAHFA 18:3/O-24:7

C42H62O4 (630.4648)

FAHFA 18:4/O-24:6

C42H62O4 (630.4648)

FAHFA 18:5/O-24:5

C42H62O4 (630.4648)

FAHFA 18:6/O-24:4

C42H62O4 (630.4648)

FAHFA 19:3/O-23:7

C42H62O4 (630.4648)

FAHFA 19:4/O-23:6

C42H62O4 (630.4648)

FAHFA 19:5/O-23:5

C42H62O4 (630.4648)

FAHFA 19:6/O-23:4

C42H62O4 (630.4648)

FAHFA 20:3/O-22:7

C42H62O4 (630.4648)

FAHFA 20:4/O-22:6

C42H62O4 (630.4648)

FAHFA 20:5/O-22:5

C42H62O4 (630.4648)

FAHFA 20:6/O-22:4

C42H62O4 (630.4648)

FAHFA 21:3/O-21:7

C42H62O4 (630.4648)

FAHFA 21:4/O-21:6

C42H62O4 (630.4648)

FAHFA 21:5/O-21:5

C42H62O4 (630.4648)

FAHFA 21:6/O-21:4

C42H62O4 (630.4648)

FAHFA 21:7/O-21:3

C42H62O4 (630.4648)

FAHFA 22:4/O-20:6

C42H62O4 (630.4648)

FAHFA 22:5/O-20:5

C42H62O4 (630.4648)

FAHFA 22:6/O-20:4

C42H62O4 (630.4648)

FAHFA 22:7/O-20:3

C42H62O4 (630.4648)

FAHFA 23:4/O-19:6

C42H62O4 (630.4648)

FAHFA 23:5/O-19:5

C42H62O4 (630.4648)

FAHFA 23:6/O-19:4

C42H62O4 (630.4648)

FAHFA 23:7/O-19:3

C42H62O4 (630.4648)

FAHFA 24:4/O-18:6

C42H62O4 (630.4648)

FAHFA 24:5/O-18:5

C42H62O4 (630.4648)

FAHFA 24:6/O-18:4

C42H62O4 (630.4648)

FAHFA 24:7/O-18:3

C42H62O4 (630.4648)

FAHFA 25:5/O-17:5

C42H62O4 (630.4648)

FAHFA 25:6/O-17:4

C42H62O4 (630.4648)

FAHFA 25:7/O-17:3

C42H62O4 (630.4648)

FAHFA 26:5/O-16:5

C42H62O4 (630.4648)

FAHFA 26:6/O-16:4

C42H62O4 (630.4648)

FAHFA 26:7/O-16:3

C42H62O4 (630.4648)

FAHFA 42:10;O

C42H62O4 (630.4648)

DG 38:11

C41H58O5 (630.4284)

MGDG 10:0_15:1

C34H62O10 (630.4343)

MGDG 11:0_14:1

C34H62O10 (630.4343)

MGDG 25:1

C34H62O10 (630.4343)

MGDG O-25:2;O

C34H62O10 (630.4343)

MGDG O-26:1

C35H66O9 (630.4707)

MGMG 26:1

C35H66O9 (630.4707)

MGGA 25:1

C34H62O10 (630.4343)

PA O-14:0/18:2

C35H67O7P (630.4624)

PA O-14:1/18:1

C35H67O7P (630.4624)

PA O-16:1/16:1

C35H67O7P (630.4624)

PA O-16:2/16:0

C35H67O7P (630.4624)

PA O-18:0/13:3;O

C34H63O8P (630.426)

PA O-18:1/14:1

C35H67O7P (630.4624)

PA O-18:2/14:0

C35H67O7P (630.4624)

PA O-20:2/12:0

C35H67O7P (630.4624)

PA O-22:2/10:0

C35H67O7P (630.4624)

PA O-31:3;O

C34H63O8P (630.426)

PA P-14:0/18:1

C35H67O7P (630.4624)

PA P-14:0/18:1 or PA O-14:1/18:1

C35H67O7P (630.4624)

PA P-16:0/16:1

C35H67O7P (630.4624)

PA P-16:0/16:1 or PA O-16:1/16:1

C35H67O7P (630.4624)

PA P-16:1/16:0

C35H67O7P (630.4624)

PA P-16:1/16:0 or PA O-16:2/16:0

C35H67O7P (630.4624)

PA P-18:0/14:1

C35H67O7P (630.4624)

PA P-18:0/14:1 or PA O-18:1/14:1

C35H67O7P (630.4624)

PA P-18:1/14:0

C35H67O7P (630.4624)

PA P-18:1/14:0 or PA O-18:2/14:0

C35H67O7P (630.4624)

PA P-20:0/11:2;O

C34H63O8P (630.426)

PA P-20:1/12:0

C35H67O7P (630.4624)

PA P-20:1/12:0 or PA O-20:2/12:0

C35H67O7P (630.4624)

PA P-22:1/10:0

C35H67O7P (630.4624)

PA P-22:1/10:0 or PA O-22:2/10:0

C35H67O7P (630.4624)

PA P-32:1

C35H67O7P (630.4624)

PA P-32:1 or PA O-32:2

C35H67O7P (630.4624)

PA 11:0_20:2

C34H63O8P (630.426)

PA 13:0_18:2

C34H63O8P (630.426)

PA 14:0_17:2

C34H63O8P (630.426)

PA 14:1_17:1

C34H63O8P (630.426)

PA 15:1_16:1

C34H63O8P (630.426)

LPEth 30:2

C35H67O7P (630.4624)

LPM 31:2

C35H67O7P (630.4624)

PEth 29:2

C34H63O8P (630.426)

PM 30:2

C34H63O8P (630.426)

CerPE 12:2;O2/19:1;O

C33H63N2O7P (630.4373)

CerPE 14:0;O2/18:2

C34H67N2O6P (630.4736)

CerPE 14:1;O2/18:1

C34H67N2O6P (630.4736)

CerPE 14:2;O2/18:0

C34H67N2O6P (630.4736)

CerPE 15:0;O2/17:2

C34H67N2O6P (630.4736)

CerPE 15:1;O2/17:1

C34H67N2O6P (630.4736)

CerPE 15:2;O2/17:0

C34H67N2O6P (630.4736)

CerPE 16:1;O2/16:1

C34H67N2O6P (630.4736)

CerPE 16:2;O2/16:0

C34H67N2O6P (630.4736)

CerPE 17:1;O2/15:1

C34H67N2O6P (630.4736)

CerPE 17:2;O2/15:0

C34H67N2O6P (630.4736)

CerPE 18:1;O2/14:1

C34H67N2O6P (630.4736)

CerPE 18:2;O2/14:0

C34H67N2O6P (630.4736)

CerPE 19:2;O2/13:0

C34H67N2O6P (630.4736)

CerPE 20:2;O2/12:0

C34H67N2O6P (630.4736)

CerPE 21:2;O2/11:0

C34H67N2O6P (630.4736)

CerPE 22:2;O2/10:0

C34H67N2O6P (630.4736)

SM 14:1;O2/15:1

C34H67N2O6P (630.4736)

SM 14:2;O2/15:0

C34H67N2O6P (630.4736)

SM 15:1;O2/14:1

C34H67N2O6P (630.4736)

SM 15:2;O2/14:0

C34H67N2O6P (630.4736)

SM 16:2;O2/13:0

C34H67N2O6P (630.4736)

SM 17:2;O2/12:0

C34H67N2O6P (630.4736)

SM 18:2;O2/11:0

C34H67N2O6P (630.4736)

SM 19:2;O2/10:0

C34H67N2O6P (630.4736)

SM 29:2;O2

C34H67N2O6P (630.4736)

SM 8:0;O2/21:2

C34H67N2O6P (630.4736)

methyl (1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2z)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C41H58O5 (630.4284)

3,4,5-trihydroxyoxan-2-yl 2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoate

C37H58O8 (630.4131)

1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-14-[(2-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl dodecanoate

C37H58O8 (630.4131)

(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl (1s,3r,6s,7s,8r,11s,12s,15r,16r)-6-hydroxy-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylidene-4-oxoheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylate

C37H58O8 (630.4131)

(2s,6r)-6-[(1r,3ar,5ar,7r,9as,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-hydroxy-2-methyl-3-methylideneheptanoic acid

C37H58O8 (630.4131)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-[(acetyloxy)methyl]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C41H58O5 (630.4284)

(5-oxo-1,4-dioxacyclononacosan-2-yl)methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H62O7 (630.4495)

methyl 10-{[3-(4-methoxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C41H58O5 (630.4284)

(2s,3s,4r,5s,6r)-6-(hydroxymethyl)-2-{[(1s,2s,3s,6s,7s,9r,10s,11r,15r,18s,23s)-7-isopropyl-3,6,11,24,24-pentamethyl-19,21-dioxaheptacyclo[16.3.3.0²,¹⁴.0³,¹¹.0⁶,¹⁰.0¹⁵,²⁰.0¹⁵,²³]tetracos-13-en-9-yl]oxy}-5-methoxyoxane-3,4-diol

C37H58O8 (630.4131)

methyl (1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2e)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C41H58O5 (630.4284)

(1s,6r,14r,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-14-[(2-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl dodecanoate

C37H58O8 (630.4131)

[(2s)-5-oxo-1,4-dioxacyclononacosan-2-yl]methyl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H62O7 (630.4495)

2,4,5-trihydroxyoxan-3-yl 2-[7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoate

C37H58O8 (630.4131)

[(2s)-5-oxo-1,4-dioxacyclononacosan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H62O7 (630.4495)

(2s,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-hydroxy-2-methyl-3-methylideneheptanoic acid

C37H58O8 (630.4131)

(5s)-3-[(2r,8s,13r,14s,17r,18r)-2,8,13,14,17,18-hexahydroxytriacontyl]-5-hydroxy-5-methylfuran-2-one

C35H66O9 (630.4707)

methyl 10-{[3-(4-methoxyphenyl)prop-2-enoyl]oxy}-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate

C41H58O5 (630.4284)

methyl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2z)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C41H58O5 (630.4284)

(1s,2s,6r,10s,11r,13s,14r,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-14-[(2-methylbutanoyl)oxy]-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl dodecanoate

C37H58O8 (630.4131)

6-{7-[(4-carboxy-3-hydroxy-3-methylbutanoyl)oxy]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C37H58O8 (630.4131)

3a-[(acetyloxy)methyl]-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(4-hydroxyphenyl)prop-2-enoate

C41H58O5 (630.4284)

6,14,22,30,32,34-hexahydroxypentatriacontane-8,16,24-trione

C35H66O9 (630.4707)

(6r,14r,22r,30r,32s,34s)-6,14,22,30,32,34-hexahydroxypentatriacontane-8,16,24-trione

C35H66O9 (630.4707)

(2s,6r)-6-[(1r,3as,5ar,7r,9as,11s,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C37H58O8 (630.4131)

(2r,3r,4s,5r)-2,4,5-trihydroxyoxan-3-yl (2r)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-(acetyloxy)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoate

C37H58O8 (630.4131)

(5s)-3-[(2r,8r,13r,14s,17r,18s)-2,8,13,14,17,18-hexahydroxytriacontyl]-5-hydroxy-5-methylfuran-2-one

C35H66O9 (630.4707)

(1s,2r,6r,10r,11s,13s,14r,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-14-{[(2r)-2-methylbutanoyl]oxy}-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl dodecanoate

C37H58O8 (630.4131)

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1r,4s,5s,8r,9r,12s,13s,16s,19r)-19-methoxy-5,9,17,17-tetramethyl-8-[(2r,4e)-6-methylhepta-4,6-dien-2-yl]-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-yl]oxy}oxane-3,4,5-triol

C37H58O8 (630.4131)

3-[(2r)-2,8,13,14,17,18-hexahydroxytriacontyl]-5-hydroxy-5-methylfuran-2-one

C35H66O9 (630.4707)

(2s,6r)-6-[(1r,3as,5ar,7s,9as,11r,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C37H58O8 (630.4131)

(2s,6r)-6-[(1r,3as,5ar,7s,9as,11s,11ar)-7-{[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C37H58O8 (630.4131)

(2r)-2-[(1r,3s,3ar,5ar,7r,9as,11ar)-3-hydroxy-7-{[(3s)-3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl]oxy}-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

C37H58O8 (630.4131)